How Ketone Bodies May Help Regulate Blood Sugar in Type 1 Diabetes

People with Type 1 diabetes often have elevated levels of ketone bodies—small molecules produced when the body breaks down fat for energy. Among these, β-hydroxybutyrate (3HB) is the most abundant. While doctors have long observed that ketone and glucose levels tend to move in opposite directions, the reason why hasn't been fully understood.

New research published in Diabetes provides mechanistic insight into this relationship. The study combined observations from people following low-carbohydrate diets and continuous glucose and ketone monitoring with targeted experiments in mice and cell cultures.

In mice with streptozotocin-induced Type 1 diabetes, seven weeks of oral 3HB administration led to improved glucose metabolism and reduced liver damage related to abnormal glucose storage. Imaging studies showed decreased glucose uptake in both the liver and intestines. Laboratory analysis revealed that 3HB suppressed the overexpression of glucose transporters—the proteins that move glucose across cell membranes—and helped restore normal glycogen metabolism.

In cell culture experiments, 3HB dose-dependently reduced glucose transporter expression and glucose uptake in both liver cells and intestinal cells, suggesting a direct effect.

The researchers identified the cellular pathway responsible for these effects. 3HB works by binding to a receptor called GPR109A, which then triggers a cascade that inhibits the PI3K/AKT/mTOR pathway—a critical signaling system inside cells. This inhibition leads to reduced glucose transporter production.

When researchers blocked GPR109A or interfered with the downstream pathway using pharmacological inhibitors and gene silencing techniques, the beneficial effects of 3HB disappeared, confirming that GPR109A is essential for the mechanism.

This work provides the first detailed explanation of how ketone bodies help regulate glucose metabolism in Type 1 diabetes at the molecular level. It suggests that 3HB acts as a natural brake on glucose absorption and production, a finding that aligns with long-standing clinical observations.

However, it is important to note that this research was conducted in animals and cell cultures. Human clinical trials would be necessary to determine whether 3HB supplementation or dietary approaches that naturally increase ketones could be safe and effective as part of Type 1 diabetes management. Anyone considering dietary changes should discuss them with their diabetes care team.

Source: Diabetes. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.